Lalitkumar K Vora Editor & Author

Over 25 years experience in research and research training in the area of vaccine formulations development for chronic diseases with translational focus. In addition, extensive clinical research background, translating research from in vitro to animal models to human clinical trials to commercialization, and expertise with consulting and being on the board of pharmaceutical companies. Research has been multidisciplinary in the areas of, immunology, medicinal chemistry, biochemistry, crystallography, antigen delivery systems, vaccine design, neurology, clinical research, drug development and commercialization. Over 450 publications in immunology and/or vaccines, 18 patents and over 80 sub-patents and is an editor or on the editorial board of a number of journals. A selection of 20 articles are shown below published in the last 1 year. Dr. Lalitkumar K. Vora is a postdoctoral research fellow at the School of Pharmacy, Queen’s University, Belfast. U.K. He completed his Ph.D. (Pharmaceutics) in 2017 from the Institute of Chemical Technology, Mumbai. During his Ph.D., he received various funding for international conferences and visited Queen’s University, U.K. for six months. He has 35 international publications (i10-Index 20, H-Index 13), 2 book chapters, and 1 granted patent. Dr.Vora presented 50 peer-reviewed research work at various international conferences. His research interests include polymeric drug delivery, microneedle-assisted non-invasive drug/vaccine delivery, and long-acting drug delivery, specifically for infectious diseases Vivek P Chavda is Assistant Professor, Department of Pharmaceutics and Pharmaceutical Technology, L M College of Pharmacy, Ahmedabad, Gujarat, India. He is B Pharm and M Pharm Gold medalist at Gujarat Technological University. Before Joining to Academics, he served in the Biologics industry for almost 7 years in Research and Development of Biologics with two successful regulatory filings at Lupin Biotech (Pune) and Dr. Reddy’s Laboratory (Hyderabad). He has more than 30 national and international publications, 10 book chapters, 10 book chapters under communication, 1 patent in the pipeline and numerous newsletter articles to his credit. His research interests include the development of biologics processes and formulations, medical device development, nano-diagnostics and non-carrier formulations, longacting parenteral formulations, and nano-vaccines.